Inclusion criteria for this study were an elevated level of prostate-specific antigen (PSA) or an abnormal digital rectal examination finding and an MP-MRI that demonstrated at least 1 lesion in the prostate. Exclusion criteria included prior prostate cancer therapy and contraindication to MP-MRI. ...
Exclusion of inflammation in the differential diagnosis of an elevated prostate-specific antigen (PSA). Urol Oncol 2009;27:64-6. [PubMed: 19111800]Loeb S,Gashti S N,Catalona W J. Exclusion of inflammation in the differential diagnosis of an elevated prostate specific antigen(PSA)[J].{H}...
Circulating miRNAs in body fluids may serve as clinically important biomarkers of various malignancies, including prostate cancer. In the present study, we identified an association of elevated plasma levels of four miRNAs i.e. miR-4289, miR-326, miR-98-5p and miR-152-3p in prostate cancer pa...
The PSA test measures the blood level of prostate-specific antigen, an enzyme produced by the prostate. Increased PSA levels correlate with an increased risk for prostate cancer (Cataluna W J. “How I manage a patient with a newly elevated PSA”, 2007, CDC Cancer Conference. http://www....
Case #1 Once is not enough for a referral: a patient claims ignorance of an elevated PSA led to a late cancer diagnosis, despite many clinic visits.(LEGAL ADVISOR)Starr, David S
Having established that HAAH protein levels were elevated in cholangiocarcinoma and not in normal or proliferating bile ducts, the role of HAAH in the generation of a malignant phenotype was studied. The HAAH gene was transfected into NIH-3T3 cells and cellular changes, e.g., increased formation...
Prostate cancer experts at Docrates help if your PSA values are elevated or fluctuating At Docrates Cancer Center, frontline experts will give you comprehensive answers to your questions about prostate cancer. Whether it be a question of prostate symptoms, cancer suspicions or the treatment of alrea...
(model 1: age, PSA level, prostate volume, prostate biopsy history, and PI-RADS score), an ESR ≥ 6.8 was identified as showing an increased OR for predicting clinically significant prostate cancer (Table3). The actual rate of clinically significant prostate cancer in ESR ≥ 6.8 ...
Inclusion criteria for this study were an elevated level of prostate-specific antigen (PSA) or an abnormal digital rectal examination finding and an MP-MRI that demonstrated at least 1 lesion in the prostate. Exclusion criteria included prior prostate cancer therapy and contraindication to MP-MRI. ...
Exclusion of inflammation in the differential diagnosis of an elevated prostate-specific antigen (PSA). Urologic oncology. 2009; 27(1):64-66.Loeb S, Gashti SN, Catalona WJ. Exclusion of inflammation in the differential diagnosis of an elevated prostate-specific antigen (PSA). Urol Oncol. 2009...